Rivaroxaban offers effective extended thromboprophylaxis than enoxaparin after THA
Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: A double-blind, randomised controlled trialLancet. 2008 Jul 5;372(9632):31-9. Epub 2008 Jun 24
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
2509 patients (>18 yr old) scheduled to undergo elective total hip arthroplasty were randomized to receive either oral rivaroxaban or enoxaparin to compare both methods of thromboprophylaxis. After a 42 day follow up, extended thromboprophylaxis with rivaroxaban was significantly more effective than short-term enoxaparin plus placebo for the prevention of venous thromboembolism, including symptoma...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE